This site is intended for healthcare professionals


In this episode, Kevin looks at common questions around non-visible haematuria (NVH) – the condition formerly known as microscopic haematuria. Should we be screening for NVH? What follow-up investigations should we do for people with asymptomatic NVH? Should we change our approach for patients taking aspirin, warfarin or direct-acting oral anticoagulants (DOACs)? Finally, who should we refer and how urgently?

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.


Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)